Envarsus XR 4 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FYQJC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,424
Award facts
- Contract value 100% obligated
- $3,423.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,423.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg, a pharmaceutical product used in immunosuppressive therapy. The contract, which became effective on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio under its prime IDC encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. This Envarsus XR delivery order exemplifies the company's role in fulfilling routine pharmaceutical procurement needs for the Department of Defense's medical supply operations.
Quick answers
Who was awarded contract SPE2DB25FYQJC?
SPE2DB25FYQJC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FYQJC worth?
The government has obligated $3,424 on SPE2DB25FYQJC.
Is contract SPE2DB25FYQJC an order under another contract?
Yes. SPE2DB25FYQJC is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQJC competed?
The extent of competition for SPE2DB25FYQJC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award